Category: Clinical trials

Intellipharmaceutics Intends to Accelerate its Rexista Oxycodone XR Development Program on the Basis of Positive Feedback from the FDA

TORONTO, May 21, 2015 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and...

Novartis Investigational Dual Bronchodilator QVA149 (indacaterol/glycopyrronium) Significantly Improved Lung Function Compared to Single Bronchodilators in COPD

EAST HANOVER, N.J., May 20, 2015 Today, Novartis announced for the first time detailed results from its phase III EXPEDITION trial program for QVA149 (indacaterol/glycopyrronium) in patients with moderate-to-severe chronic obstructive pulmonary...

Takeda Announces First Patient Enrolled in Global Phase 3 Study of Ixazomib as Maintenance Therapy for Newly Diagnosed Multiple Myeloma

Cambridge, MA, and Osaka, Japan, May 12, 2015 – Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the first patient has been enrolled in the Phase 3 TOURMALINE-MM4 study of investigational oral ixazomib. This is a superiority...